Can the IBEX 35 sustain its climb?

Price at time of writing – 10,118.

One of my more adventurous calls in 2013 was for a major advance on Spain’s leading index, the IBEX 35. 

The break above pivotal resistance at 8665 triggered my high-conviction buy recommendation in July, with an ultimate target projected to be 11,810. This target remains very much intact today, and Spain continues to be one of the better countries in which to have equity exposure.

In last year’s follow-up notes on Spain – most recently on 14 October – I also highlighted a tactic suitable for shorter-term traders. This involved selling the index at 9841 (where a 66.66% rise from the July 2012 low would be fulfilled) and buying back at the G2 level of 9435. This, too, was a successful outcome, as the index dipped just beneath the G2 level in early December.

The anticipated range-trading between 9435-9841 now appears to be over. Going forward, the key question is whether the IBEX can sustain above 9841. In this respect, recent price action sends a positive signal, as this month’s break back above isolated resistance at 10,010 demonstrates.

Recommendation:  stay long. Target 11,810. Stop-losses can be raised significantly now, and activated only on momentum below 9600.

IBEX 35 chart

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.